U.S. markets open in 2 hours 55 minutes
  • S&P Futures

    4,076.75
    -4.50 (-0.11%)
     
  • Dow Futures

    34,531.00
    -68.00 (-0.20%)
     
  • Nasdaq Futures

    12,005.75
    -36.50 (-0.30%)
     
  • Russell 2000 Futures

    1,891.00
    +3.50 (+0.19%)
     
  • Crude Oil

    81.36
    +0.81 (+1.01%)
     
  • Gold

    1,792.90
    +33.00 (+1.88%)
     
  • Silver

    22.31
    +0.52 (+2.41%)
     
  • EUR/USD

    1.0443
    +0.0035 (+0.33%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    20.91
    -0.98 (-4.48%)
     
  • GBP/USD

    1.2160
    +0.0098 (+0.82%)
     
  • USD/JPY

    136.1870
    -1.8930 (-1.37%)
     
  • BTC-USD

    17,079.51
    +181.71 (+1.08%)
     
  • CMC Crypto 200

    404.54
    +3.85 (+0.96%)
     
  • FTSE 100

    7,579.48
    +6.43 (+0.08%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

Novavax Downgraded by JPMorgan Chase. Time to Sell?

Novavax Downgraded by JPMorgan Chase. Time to Sell?

The Novavax (NASDAQ: NVAX) rollercoaster has been a wild one. The stock soared more than 2,700% in 2020 after the company received $1.6 billion from the U.S. government to develop the COVID-19 vaccine we now know as Nuvaxovid. Unfortunately, Novavax didn't receive authorization to sell its vaccine in the U.S. until this July.